Showing results (161-170 of 182) with videos related to

Sort By:
Pageof 19
Molecular Psychiatry|June 27, 2022
Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysisGustavo C Medeiros, Todd D Gould, William L Prueitt, et al.
Biological Psychiatry|December 21, 2010
The Bcl-2 gene polymorphism rs956572AA increases inositol 1,4,5-trisphosphate receptor-mediated endoplasmic reticulum calcium release in subjects with bipolar disorderRodrigo Machado-Vieira, Natalia B Pivovarova, Ruslan I Stanika, et al.
Journal of Psychopharmacology (Oxford, England)|October 18, 2017
The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorderMark J Niciu, Nicolas D Iadarola, Dipavo Banerjee, et al.
Psychopharmacology|January 6, 2016
A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depressionErica M Richards, Daniel C Mathews, David A Luckenbaugh, et al.
Annals of General Psychiatry|December 4, 2025
Acceptability of active and sham home-based transcranial direct current stimulation in major depression: mixed methods qualitative analysis in a randomised controlled trialPeter J Lagerberg, Rachel D Woodham, Sudhakar Selvaraj, et al.
Psychiatry Research. Neuroimaging|May 25, 2026
Response-predictive MRI biomarkers of low-dose lithium therapy: cortical thickness changes in patients with bipolar depressionGregory H Jones, Robert Suchting, Alan C Courtes, et al.
JAMA Psychiatry|December 29, 2017
Efficacy and Safety of Transcranial Direct Current Stimulation as an Add-on Treatment for Bipolar Depression: A Randomized Clinical TrialBernardo Sampaio-Junior, Gabriel Tortella, Lucas Borrione, et al.
Nature Medicine|October 21, 2024
Home-based transcranial direct current stimulation treatment for major depressive disorder: a fully remote phase 2 randomized sham-controlled trialRachel D Woodham, Sudhakar Selvaraj, Nahed Lajmi, et al.
EJNMMI Research|July 5, 2018
PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjectsErica M Richards, Paolo Zanotti-Fregonara, Masahiro Fujita, et al.
Translational Psychiatry|March 7, 2019
Correction: Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depressionWei Guo, Rodrigo Machado-Vieira, Sanjay Mathew, et al.
Pageof 19